Merck completes acquisition of Austrian vaccine developer Themis Bioscience
Pharma giant Merck has wrapped up its previously announced acquisition of Austrian vaccine developer Themis Bioscience. The Austrian company is focused on developing vaccines and ... Read More
Merck to acquire coronavirus vaccine candidate developer Themis Bioscience
Merck acquisition of Themis Bioscience : Merck has signed a deal to acquire Themis Bioscience, an Austrian vaccine developer for an undisclosed price with an ... Read More